Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Dec 08, 2011	EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences Ablatherm-HIFU Featured in Eight Presentations at World Congress of Endourology (WCE) Ablatherm-HIFU Focal Treatment Advantages Showcased at First Montreal Conference on Focal Therapy LYON, France , Dec. 8, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic	View HTML EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences 16.1 KB
Toggle Summary Nov 16, 2011	EDAP Reports Third Quarter 2011 Financial Results - Record Third Quarter Revenues - - Sonolith i-move FDA Marketing Clearance Leads to First U.S. Sale in Fourth Quarter - Third Quarter 2011 Highlights Reported 61% sequential quarter revenue increase to EUR 6.1 million ( USD 8.6 million ) Generated strong devices sales with fourteen lithotripsy	View HTML EDAP Reports Third Quarter 2011 Financial Results 37 KB
Toggle Summary Nov 10, 2011	EDAP Generates First U.S. Sonolith i-move Lithotripter Sale Empire Litho to Utilize Compact Lithotripter on Mobile Basis at Six New York City Metro Hospitals US Sale Recorded Three Months Following U.S. FDA 510(k) Clearance LYON, France , Nov. 10, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced it	View HTML EDAP Generates First U.S. Sonolith i-move Lithotripter Sale 16.3 KB
Toggle Summary Oct 19, 2011	EDAP Schedules Webcast and Conference Call of Third Quarter 2011 Results LYON, France , Oct. 19, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2011 results announcement, which will take place on Wednesday, November 16, 2011 , before the opening of the market.	View HTML EDAP Schedules Webcast and Conference Call of Third Quarter 2011 Results 14.6 KB
Toggle Summary Oct 13, 2011	EDAP Reports 61% Sequential Revenue Increase for Third Quarter 2011 Top-Line Results Fueled by Sale of Fifteen Devices	View HTML EDAP Reports 61% Sequential Revenue Increase for Third Quarter 2011 14.8 KB
Toggle Summary Oct 06, 2011	EDAP Receives Sonolith i-move Approval in Russia LYON, France , Oct. 6, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today it has received marketing clearance from the Russian Federal Healthcare Department for its Sonolith i-move device, a technologically advanced compact mobile	View HTML EDAP Receives Sonolith i-move Approval in Russia 14.3 KB
Toggle Summary Sep 06, 2011	EDAP to Present at Rodman & Renshaw Annual Global Investment Conference LYON, France , Sept. 6, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Eric Soyer , Chief Financial Officer, is scheduled to present at the Rodman & Renshaw Annual Global Investment Conference that will be held in New York City	View HTML EDAP to Present at Rodman & Renshaw Annual Global Investment Conference 14.1 KB
Toggle Summary Aug 30, 2011	EDAP Reports Second Quarter 2011 Financial Results Sonolith i-move Approved by U.S. FDA	View HTML EDAP Reports Second Quarter 2011 Financial Results 36.7 KB
Toggle Summary Aug 24, 2011	EDAP Partnership Wins EUR 2.4 Million Grant for Development of Innovative Imaging Solution for Focal Treatment of Prostate Cancer LYON, France , Aug. 24, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its development partnership has been awarded a EUR 2.4 million grant for further development of Ablatherm-HIFU technology to incorporate improved imaging and	View HTML EDAP Partnership Wins EUR 2.4 Million Grant for Development of Innovative Imaging Solution for Focal Treatment of Prostate Cancer 20.1 KB
Toggle Summary Aug 03, 2011	EDAP Gains U.S. FDA 510(k) Lithotripter Clearance Innovative Compact Sonolith(R) i-move Lithotripter Expands U.S. Market Potential	View HTML EDAP Gains U.S. FDA 510(k) Lithotripter Clearance 15.1 KB